Clinical Trial: An Open-label, Rollover Trial to Evaluate the Efficacy and Safety of AMG 732 in Participants With Thyroid Eye Disease

U.S., Feb. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07438405) titled 'An Open-label, Rollover Trial to Evaluate the Efficacy and Safety of AMG 732 in Participants With Thyroid Eye Disease' on Feb. 23.

Brief Summary: The main objective of this trial is to assess the efficacy of AMG 732 in participants with thyroid eye disease (TED) who are defined as primary nonresponders or relapsed during the safety follow-up in the parent trial (NCT06401044).

Study Start Date: Feb. 25

Study Type: INTERVENTIONAL

Condition: Thyroid Eye Disease

Intervention: DRUG: AMG 732

AMG 732 will be administered SC.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Amgen

Published by HT Digital Content Services with permis...